Results 281 to 290 of about 615,884 (310)
Some of the next articles are maybe not open access.
Tumor Stage in Non-Small Cell Carcinoma of the Lung
Chest, 1991This article is the second in a planned series from the Section on Cancer of the ACCP. The first article (Little AG, Stitik FP: Clinical staging of patients with non-small cell lung cancer. Chest 97:1431-38, 1990) focused on clinical approaches to staging and emphasized the role of: (1) radionuclide scanning; (2) computed tomography; (3) magnetic ...
C F, Mountain +2 more
openaire +2 more sources
Drugs, 1995
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies in developed countries and accounts for millions of deaths worldwide. The incidence of NSCLC correlates with smoking tobacco and is likely to increase in those countries with increasing per capita consumption of tobacco.
K T, Bastin, R, Curley
openaire +2 more sources
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies in developed countries and accounts for millions of deaths worldwide. The incidence of NSCLC correlates with smoking tobacco and is likely to increase in those countries with increasing per capita consumption of tobacco.
K T, Bastin, R, Curley
openaire +2 more sources
Elastase levels in small and non - small cell lung carcinoma
Biochemical Society Transactions, 1993Elastase (E.C.3.4.21.37) constitutes the most important component in the proteolytic enzyme spectrum of neutrophilic granulocytes [ I ] . Elastase is the only enzyme which can hydrolyze insoluble elastin 121. In addition, elastase can hydrolyze several other tissue components including connective tissue macromolecules, plasma proteinase inhibitors and ...
Güner, G +4 more
openaire +4 more sources
Chromogranin A gene expression in non‐small cell lung carcinomas
The Journal of Pathology, 1998Evidence for the existence of neuroendocrine (NE) differentiation in non-small cell lung carcinomas (NSCLCs) is at present based on histochemical, ultrastructural, and immunohistochemical data. The aim of this study was to investigate the extent of NE differentiation in NSCLCs as revealed by mRNA analysis.
ABBONA G. +5 more
openaire +3 more sources
[Diagnostics of non-small cell lung carcinoma].
Duodecim; laaketieteellinen aikakauskirja, 2014ALK inhibitor therapy is individual cancer treatment, in which the targeted drug therapy is directed to a patient group that is likely to benefit from the therapy. The detection in the tumor of ALK gene (anaplastic lymphoma kinase) rearrangement is a prerequisite for the ALK inhibitor therapy for non-small cell lung carcinoma.
Kaisa, Salmenkivi, Aija, Knuuttila
openaire +1 more source
Surgical adjuvant chemotherapy in non-small cell carcinoma of the lung
International Journal of Radiation Oncology*Biology*Physics, 1980A review of the published clinical trials of surgical adjuvant chemotherapy in lung cancer indicated that in the majority of nonrandomized trials, conclusions favored the use of adjuvant chemotherapy. On the other hand, most randomized trials were unable to show any statistically significant difference in survival or disease-free interval between ...
openaire +2 more sources